The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway.
 
Markus Joerger
No Relationships to Disclose
 
Philippe Alexandre Cassier
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst); Toray Industries (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Novartis; Roche
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Richard Cathomas
Consulting or Advisory Role - Amgen; Astellas Oncology; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; Roche
 
Heike Richly
No Relationships to Disclose
 
Martin Schostak
No Relationships to Disclose
 
Andreas Janitzky
Consulting or Advisory Role - Roche
 
Martin Wermke
Consulting or Advisory Role - Bristol-Myers Squibb; Glenmark; MSD; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Glenmark
 
Lucia Nogova
Honoraria - Celgene; Novartis; Pfizer; Pfizer
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Novartis; Pfizer
 
David Wai-Meng Tai
No Relationships to Disclose
 
Cyrus Sayehli
No Relationships to Disclose
 
Carsten Grüllich
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
 
Enrique Grande
No Relationships to Disclose
 
Alejandro Navarro
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Se Hoon Park
No Relationships to Disclose
 
Hendrik Nogai
Employment - Bayer
 
Sebastian Bender
Employment - Bayer
 
Peter Ellinghaus
Employment - Bayer
 
Martin H. Schuler
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)